Journal profile · Medicine-Orthopedics and Sports Medicine
JBMR Plus
ISSN 2473-4039 · Wiley-Blackwell · United States
JBMR Plus: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.6 (journal website); fully open access; APC about USD 2,750; median 130 days to acceptance (103 articles, last 24 months); 204 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
JBMR Plus is published by Wiley-Blackwell and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bone health and osteoporosis research, Bone health and treatments and Bone Metabolism and Diseases, together about 41.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JBMR® Plus is the open-access journal of the American Society for Bone and Mineral Research (ASBMR). A companion to internationally recognized title Journal of Bone and Mineral Research (JBMR®), JBMR® Plus aims to improve global musculoskeletal health by publishing sound but focused and rigorous studies and innovative research. We welcome replication studies and “negative results,” and reports on “omics” datasets without extensive mechanistic validation. Our goal with this journal is to provide rapid decisions and publish papers that stimulate discussion and debate as well as add to our knowledge base. Journal metrics Citation metrics Clarivate 2025 Impact Factor 3.0 2025 5 Year Impact Factor 3.6 Endocrinology & Metabolism (Rank by Impact Factor) 111/198 Scopus 2025 CiteScore 3.8 Orthopedics And Sports Medicine (Rank by CiteScore) 118/340 About metrics Disclaimer Statements of fact and opinion in the articles in JBMR Plus are those of the respective authors and contributors and not of the Journal, American Society for Bone and Mineral Research, or Oxford University Press, unless otherwise expressly indicated. Neither Oxford University Press, American Society for Bone and Mineral Research, nor the Journal make any representation, express or implied, in respect of the accuracy of the material in the Journal and cannot accept any legal responsibility or liability for any errors or omissions that may be made. Readers should make their own evaluation as to the appropriateness or otherwise of the information included.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Orthopedics and Sports Medicine
Editor-in-chief Deborah VeisPublisher website
Editorial board by country: none in mainland China; most named United States 25, Germany 4, Japan 3, South Korea 2, Canada 2 (37 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bone health and osteoporosis researchMedicine18.4%
- Bone health and treatmentsMedicine12.3%
- Bone Metabolism and DiseasesBiochemistry, Genetics and Molecular Biology10.6%
- Parathyroid Disorders and TreatmentsMedicine8.1%
- Bone and Joint DiseasesMedicine5%
- Connective tissue disorders researchBiochemistry, Genetics and Molecular Biology4.2%
- Vitamin D Research StudiesMedicine4.1%
- Hip and Femur FracturesMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.6Publisher website ·
- CiteScore 2026-06
- 3.8LetPub ·
- CiteScore (publisher) 2025
- 3.8Publisher website ·
- SJR 2026-06
- 1.01LetPub ·
- SNIP 2026-06
- 1.01LetPub ·
- h-index
- 50OpenAlex ·
- i10-index
- 398OpenAlex ·
- 2-year mean citedness
- 2.99OpenAlex ·
- Self-citation rate
- 6.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 183LetPub ·
Articles by year OpenAlex count · 1,350 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 156 | 156 | 38 |
| 2025 | 204 | 204 | 433 |
| 2024 | 194 | 194 | 1,186 |
| 2023 | 148 | 148 | 922 |
| 2022 | 121 | 121 | 1,198 |
| 2021 | 159 | 159 | 2,549 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
130 daysMedian, submission to acceptance · P25–P75 94 days – 175 days
- Acceptance to online
- median 11 days (103 articles)
- Submission to online
- median 148 days
- Sample
- 103 articles with submission and acceptance dates (403 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,750 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,888 | — | — | |
| LetPub | USD 2,600 / GBP 1,750 / EUR 2,350 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- United States
- Language
- English
- ISSN
- 2473-4039
- Latest issue on the website
- Volume 10, Issue 10 (October 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JBMR Plus
What CAS zone is JBMR Plus in?
In the 2025 upgraded edition of the CAS Journal Ranking, JBMR Plus is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JBMR Plus?
The journal's website gives an impact factor of 3.6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.8, h-index 50.
How long does peer review take at JBMR Plus?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 130 days (interquartile range 94–175 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of JBMR Plus based?
Of the 37 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (25), Germany (4) and Japan (3). Counted from the institutions listed on the board page; for reference only.
Which databases index JBMR Plus?
According to LetPub and DOAJ records, JBMR Plus is indexed in ESCI, Scopus and DOAJ.
Is JBMR Plus open access, and what is the APC?
JBMR Plus is a fully open-access journal. APC about USD 2,750.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .